| Gonal-f |
020378 |
003 |
351(a) |
follitropin alfa |
For Injection |
Subcutaneous |
37.5IU |
Ampule |
2004/03/25
|
EMD Serono, Inc. |
Disc |
Licensed |
N/A |
N/A |
| Gonal-f RFF |
021765 |
001 |
351(a) |
follitropin alfa |
For Injection |
Subcutaneous |
37.5IU |
Single-Dose Vial |
2004/03/25
|
EMD Serono, Inc. |
Disc |
Licensed |
N/A |
N/A |
| Gonal-f RFF |
021765 |
002 |
351(a) |
follitropin alfa |
For Injection |
Subcutaneous |
75IU |
Single-Dose Vial |
2004/03/25
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Gonal-f RFF |
021765 |
003 |
351(a) |
follitropin alfa |
For Injection |
Subcutaneous |
150IU |
Single-Dose Vial |
2004/03/25
|
EMD Serono, Inc. |
Disc |
Licensed |
N/A |
N/A |
| Follistim AQ Cartridge |
021211 |
001 |
351(a) |
follitropin beta |
Injection |
Subcutaneous |
300IU/0.36ML |
Multi-Dose Cartridge |
2004/03/23
|
Organon USA LLC, a subsidiary of Organon & Co. |
Rx |
Licensed |
N/A |
N/A |
| Follistim AQ Cartridge |
021211 |
002 |
351(a) |
follitropin beta |
Injection |
Subcutaneous |
600IU/0.72ML |
Multi-Dose Cartridge |
2004/03/23
|
Organon USA LLC, a subsidiary of Organon & Co. |
Rx |
Licensed |
N/A |
N/A |
| Monoclate, Monoclate-P |
103953 |
004 |
351(a) |
Antihemophilic Factor (Human) |
For Injection |
Intravenous |
1500IU |
Vial |
2004/03/04
|
CSL Behring LLC |
Disc |
Voluntarily Revoked |
|
N/A |
| Avastin |
125085 |
001 |
351(a) |
bevacizumab |
Injection |
Intravenous |
100MG/4ML (25MG/ML) |
Single-Dose Vial |
2004/02/26
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Avastin |
125085 |
002 |
351(a) |
bevacizumab |
Injection |
Intravenous |
400MG/16ML (25MG/ML) |
Single-Dose Vial |
2004/02/26
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Rhophylac |
125070 |
001 |
351(a) |
Rho(D) Immune Globulin Intravenous (Human) |
Injection |
Intramuscular |
1500IU/ML |
Pre-Filled Syringe |
2004/02/12
|
CSL Behring AG |
Rx |
Licensed |
|
N/A |
| Rhophylac |
125070 |
002 |
351(a) |
Rho(D) Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
1500IU/ML |
Pre-Filled Syringe |
2004/02/12
|
CSL Behring AG |
Rx |
Licensed |
|
N/A |
| Erbitux |
125084 |
001 |
351(a) |
cetuximab |
Injection |
Intravenous |
100MG/50ML (2MG/ML) |
Single-Dose Vial |
2004/02/12
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Pegasys |
103964 |
002 |
351(a) |
peginterferon alfa-2a |
Injection |
Subcutaneous |
180MCG/0.5ML |
Pre-Filled Syringe |
2004/01/07
|
pharmaand GmbH |
Rx |
Licensed |
N/A |
N/A |
| Flebogamma 5%, Flebogamma 5% Dif |
125077 |
001 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
0.5G/10ML |
Single-Dose Vial |
2003/12/15
|
Instituto Grifols, S.A. |
Disc |
Licensed |
|
N/A |
| Flebogamma 5%, Flebogamma 5% Dif |
125077 |
002 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
2.5G/50ML |
Single-Dose Vial |
2003/12/15
|
Instituto Grifols, S.A. |
Disc |
Licensed |
|
N/A |
| Flebogamma 5%, Flebogamma 5% Dif |
125077 |
003 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5G/100ML |
Single-Dose Vial |
2003/12/15
|
Instituto Grifols, S.A. |
Rx |
Licensed |
|
N/A |
| Flebogamma 5%, Flebogamma 5% Dif |
125077 |
004 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
10G/200ML |
Single-Dose Vial |
2003/12/15
|
Instituto Grifols, S.A. |
Rx |
Licensed |
|
N/A |
| Aranesp |
103951 |
020 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
25MCG/0.42ML |
Pre-Filled Syringe |
2003/12/12
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
021 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
25MCG/0.42ML |
Pre-Filled Syringe |
2003/12/12
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Aranesp |
103951 |
022 |
351(a) |
darbepoetin alpha |
Injection |
Intravenous, Subcutaneous |
40MCG/0.4ML |
Pre-Filled Syringe |
2003/12/12
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |